The board of directors of Sinco Pharmaceuticals Holdings Limited announced that Mr. Hao Jinghui (Mr. Hao) has been appointed as the co-chief executive officer of the company with effect from 16 August 2016. Upon the appointment, Mr. Hao, together with the current chief executive officer, Mr. Huang Xiangbin, will act as co-chief executive officers of the company and are responsible together for the Groups overall business development, operation and management.